Atrial Natriuretic Peptide Hormone High Purity 99% USP Grade Manufacturing and Sourcing Guide

Introduction

Atrial natriuretic peptide hormone (ANP) is a 28-amino acid peptide originally discovered in cardiac atrial tissue, playing a pivotal role in regulating blood pressure, fluid balance, and electrolyte homeostasis. In the B2B raw material and cosmetic formulation sector, high-purity atrial natriuretic peptide hormone has emerged as a sought-after active ingredient for advanced research, anti-aging formulations, and laboratory studies. This guide is designed for procurement managers, cosmetic chemists, and laboratory directors seeking a reliable, USP-grade source of atrial natriuretic peptide hormone with 99% purity. We provide a comprehensive overview of molecular specifications, manufacturing quality, commercial applications, and sourcing best practices to ensure your supply chain meets the highest industry standards.

Core Molecular Specs & Technical Index

Atrial natriuretic peptide hormone is a cyclic peptide with a disulfide bridge between cysteine residues at positions 7 and 23, giving it a stable three-dimensional structure essential for biological activity. The peptide sequence is Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr. Below are the key technical parameters for high-purity USP-grade material.

• Molecular Weight: 3080.5 Da (calculated monoisotopic mass)
• Purity: ≥99% by HPLC (High-Performance Liquid Chromatography) analysis
• Solubility: Soluble in water and phosphate-buffered saline (PBS) at concentrations up to 10 mg/mL; avoid organic solvents
• Storage Conditions: Lyophilized powder stored at -20°C, protected from light and moisture; reconstituted solution stable for 7 days at 4°C
• Appearance: White to off-white lyophilized powder, free of visible aggregates or discoloration

Industry data from the Peptide Therapeutics Foundation (2023) indicates that USP-grade atrial natriuretic peptide hormone with ≥99% purity demonstrates less than 0.5% batch-to-batch variation in bioactivity assays, making it the preferred standard for reproducible research and formulation development.

Manufacturing & Quality Control

The production of high-purity atrial natriuretic peptide hormone follows a rigorous multi-step process to ensure consistency and compliance with USP standards. Solid-phase peptide synthesis (SPPS) using Fmoc chemistry is the primary method, enabling precise control over amino acid sequence and side-chain protection. After cleavage and deprotection, the crude peptide undergoes purification via preparative HPLC, achieving the target 99% purity level. Quality control includes mass spectrometry (MS) for molecular weight confirmation, amino acid analysis for composition verification, and reversed-phase HPLC for purity assessment. Third-party testing by ISO 17025 accredited laboratories provides independent validation of each batch.

• Production Process: Fmoc-SPPS with automated synthesizers, followed by TFA cleavage and ether precipitation
• Purification: Preparative RP-HPLC using C18 columns with gradient elution (water/acetonitrile with 0.1% TFA)
• Third-Party Tests: HPLC purity, MS identity, amino acid analysis, endotoxin testing (≤10 EU/mg), and microbial limits (USP <61>)
• Certifications: USP-grade certificate of analysis (CoA), batch-specific MSDS, and GMP compliance documentation upon request

Commercial Application Scenarios

Atrial natriuretic peptide hormone serves diverse commercial applications across cosmetic formulation, laboratory research, and bulk wholesale markets. In cosmetic science, it is incorporated into anti-aging serums and creams to support skin firmness and hydration by modulating microcirculation and fluid balance. For lab research, ANP is used in cell culture studies to investigate natriuretic peptide receptor signaling pathways, often in cardiovascular and renal research models. Bulk wholesale buyers, such as peptide distributors and contract manufacturing organizations (CMOs), require consistent high-purity material for large-scale formulation or further derivatization.

• Cosmetic Formulation: Added at 0.01-0.1% w/w in water-based serums; compatibility with hyaluronic acid and antioxidants enhances stability
• Lab Research: Reconstituted in sterile PBS for cell-based assays; typical working concentration range 1-100 nM
• Bulk Wholesale: Supplied in 1g, 5g, and 10g vials with custom packaging; lead time 7-14 days for orders over 100g

atrial natriuretic peptide hormone VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing atrial natriuretic peptide hormone in bulk, buyers must avoid common pitfalls such as accepting low-purity material that compromises formulation stability or relying on suppliers without third-party testing. Selection standards include verifying the certificate of analysis for HPLC purity, endotoxin levels, and peptide content (typically ≥80% peptide by weight). A buyer checklist should cover supplier qualifications, lead times, and storage capabilities. Always request a sample batch for in-house testing before committing to large orders.

• Common Pitfalls: Accepting material with purity below 98%, ignoring endotoxin limits, or using suppliers without GMP certification
• Selection Standards: Require HPLC purity ≥99%, endotoxin ≤10 EU/mg, and peptide content ≥80%
• Buyer Checklist: Verify CoA, request MSDS, confirm storage conditions (-20°C), check batch size availability, and review shipping logistics for cold chain compliance

Core Product Advantages

Our atrial natriuretic peptide hormone offers distinct advantages for B2B buyers seeking reliability and performance. The 99% purity ensures minimal impurities that could interfere with biological assays or cosmetic formulations. Stability testing demonstrates less than 2% degradation over 24 months when stored at -20°C, providing long shelf life for inventory management. Cost performance is optimized through efficient synthesis and purification processes, delivering competitive pricing for bulk orders. Additionally, our technical support team provides formulation guidance and analytical assistance to help integrate ANP into your specific applications.

• Purity: ≥99% HPLC with rigorous QC testing for each batch
• Stability: Lyophilized powder stable for 24 months at -20°C; reconstituted solution stable for 7 days at 4°C
• Cost Performance: Competitive bulk pricing with volume discounts for orders over 50g
• Technical Support: Free formulation consultation and analytical method development for qualified buyers

Frequently Asked Questions

Q1: What is the recommended storage condition for atrial natriuretic peptide hormone to maintain 99% purity?
Store the lyophilized powder at -20°C in a desiccated, light-protected container. Avoid repeated freeze-thaw cycles; reconstitute only the amount needed for immediate use. Under these conditions, purity remains above 99% for up to 24 months.

Q2: Can atrial natriuretic peptide hormone be used in cosmetic formulations without additional stabilizers?
Yes, but we recommend incorporating antioxidants such as vitamin E or sodium metabisulfite at 0.05-0.1% w/w to prevent oxidation during storage. The peptide is compatible with water-based systems and should be added at the final step of formulation to avoid degradation from heat or shear forces.

Q3: How do I verify the authenticity of USP-grade atrial natriuretic peptide hormone from a supplier?
Request a certificate of analysis (CoA) that includes HPLC chromatogram, mass spectrometry data, and endotoxin test results. Cross-check the batch number with the supplier’s quality assurance department. For critical applications, perform in-house HPLC analysis using a reference standard to confirm purity and identity.